AR090726A1 - Vacunas y procedimientos para tratar la enfermedad de lyme en perros - Google Patents
Vacunas y procedimientos para tratar la enfermedad de lyme en perrosInfo
- Publication number
- AR090726A1 AR090726A1 ARP130101267A ARP130101267A AR090726A1 AR 090726 A1 AR090726 A1 AR 090726A1 AR P130101267 A ARP130101267 A AR P130101267A AR P130101267 A ARP130101267 A AR P130101267A AR 090726 A1 AR090726 A1 AR 090726A1
- Authority
- AR
- Argentina
- Prior art keywords
- vaccines
- dogs
- procedures
- disease
- immunogenic composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composición inmunógena que comprende un fragmento antigénico de proteína OspA de Borrelia burgdorferi y una proteína quimérica que contiene fragmentos antigénicos de diferentes filotipos de proteína OspC de Borrelia burgdorferi. También vacunas que incorporan la composición inmunógena de la presente, así como procedimientos para prevenir la enfermedad de Lyme en perros y/o proteger perros de la enfermedad de Lyme usando las vacunas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261635031P | 2012-04-18 | 2012-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR090726A1 true AR090726A1 (es) | 2014-12-03 |
Family
ID=48193279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP130101267A AR090726A1 (es) | 2012-04-18 | 2013-04-17 | Vacunas y procedimientos para tratar la enfermedad de lyme en perros |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2838555A2 (es) |
JP (1) | JP2015514776A (es) |
CN (1) | CN104379164A (es) |
AR (1) | AR090726A1 (es) |
AU (1) | AU2013249229A1 (es) |
BR (1) | BR112014025740A2 (es) |
CA (1) | CA2870179C (es) |
EA (1) | EA201491668A1 (es) |
UY (1) | UY34745A (es) |
WO (1) | WO2013158818A2 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016057793A1 (en) * | 2014-10-08 | 2016-04-14 | Virginia Commonwealth University | Stage specific diagnostic antigens, assay and vaccine for lyme disease |
CA3082959A1 (en) * | 2017-12-04 | 2019-06-13 | Intervet International B.V. | Canine lyme disease vaccine |
CN110483624B (zh) * | 2019-08-22 | 2021-02-09 | 中国疾病预防控制中心传染病预防控制所 | 伽氏疏螺旋体OspA蛋白C端肽段及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4567042A (en) | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
US4567043A (en) | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
US6872550B1 (en) | 1991-07-11 | 2005-03-29 | Baxter Vaccine Ag | Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens |
EP0877085A1 (en) * | 1991-08-15 | 1998-11-11 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | OspA protein of borrelia burgdorferi subgroups, encoding genes and vaccines |
DE69938183T2 (de) | 1998-07-31 | 2009-02-19 | Gundersen Lutheran Medical Foundation, Inc., La Crosse | Verwendungen eines borreliaziden epitops des aussermembranproteins c von borrelia burgdorferi (ospc) als impstoff |
US20110262475A1 (en) | 2008-05-02 | 2011-10-27 | Earnhart Christopher G | Lyme disease vaccine |
WO2010132758A2 (en) * | 2009-05-14 | 2010-11-18 | Gomes-Solecki Maria J | Ospc-based diagnostic test for lyme disease |
BR112013009588A2 (pt) * | 2010-10-20 | 2017-10-10 | Univ Virginia Commonwealth | vacinógeno ospc quimérico polivalente e antígeno para diagnóstico |
-
2013
- 2013-04-16 UY UY0001034745A patent/UY34745A/es not_active Application Discontinuation
- 2013-04-17 AR ARP130101267A patent/AR090726A1/es unknown
- 2013-04-18 EA EA201491668A patent/EA201491668A1/ru unknown
- 2013-04-18 CN CN201380030342.1A patent/CN104379164A/zh active Pending
- 2013-04-18 AU AU2013249229A patent/AU2013249229A1/en not_active Abandoned
- 2013-04-18 JP JP2015507162A patent/JP2015514776A/ja active Pending
- 2013-04-18 WO PCT/US2013/037063 patent/WO2013158818A2/en active Application Filing
- 2013-04-18 EP EP13719257.1A patent/EP2838555A2/en not_active Withdrawn
- 2013-04-18 CA CA2870179A patent/CA2870179C/en active Active
- 2013-04-18 BR BR112014025740A patent/BR112014025740A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2870179A1 (en) | 2013-10-24 |
JP2015514776A (ja) | 2015-05-21 |
WO2013158818A2 (en) | 2013-10-24 |
AU2013249229A1 (en) | 2014-10-23 |
UY34745A (es) | 2013-11-29 |
BR112014025740A2 (pt) | 2017-07-04 |
CN104379164A (zh) | 2015-02-25 |
CA2870179C (en) | 2018-09-04 |
WO2013158818A3 (en) | 2014-04-17 |
EP2838555A2 (en) | 2015-02-25 |
EA201491668A1 (ru) | 2015-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267997A (en) | Preparations, formulations and methods for treating eye diseases | |
MX2012013264A (es) | Quimeras ospa y su uso en vacunas. | |
BR112012005225B8 (pt) | Uso de uma proteína de fusão actriib-fc para o tratamento de um transtorno relacionado ao osso ou associado à perda de músculo por crescimento muscular insuficiente | |
CO7151522A2 (es) | Proteínas de fusión de interleuquina-10 y usos de las mismas | |
CO7160093A2 (es) | Anticuerpos anti-egfr y usos de los mismos | |
PH12015500092A1 (en) | Compositions for immunising against staphylococcus aureus | |
IL257057A (en) | Biologically active peptides derived from soy for use in preparations and methods for wound healing, tissue engineering and regenerative medicine | |
MX2015011199A (es) | Agentes terapéuticos de csf1. | |
BR112014023937A2 (pt) | composição farmacêutica, agente farmacêutico de combinação e método de tratamento | |
AR090465A1 (es) | Formas solidas de un profarmaco de nucleotidos de tiofosforamidato | |
EP3845241A8 (en) | Long lasting effect of new botulinum toxin formulations | |
DOP2013000235A (es) | Proteínas de fusión y vacunas de combinación que comprenden proteína e y pilina a de haemophilus influenzae. | |
BR112016013109A2 (pt) | anticorpos de anti-siglec-8 e métodos de seu uso | |
CL2015003343A1 (es) | Composición farmacéutica que comprende un agente terapéutico modificado en base a hemoglobina, para el tratamiento para tratar el cáncer, e imágenes de diagnóstico. | |
EP2898064A4 (en) | COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF LESION AND TISSUE DISEASE | |
IN2015DN02729A (es) | ||
TR201910866T4 (tr) | Kanser tedavisi için birleşik preparasyonlar. | |
UA114286C2 (uk) | Спосіб лікування staphylococcus aureus | |
NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
AR094851A1 (es) | COMPUESTOS BICíCLICOS COMO AGONISTAS DE S1P₁ | |
WO2015084883A3 (en) | Compositions and methods for treating osteoarthritis | |
BR112015016033A8 (pt) | composições farmacêuticas para tratamento de infecções por bactérias, e seus usos | |
BR112015001843A2 (pt) | dispositivo médico, composição de matriz biodegradável e método para tratar um paciente. | |
CL2015003563A1 (es) | Marcador para trastornos de la esfingomielinasa ácida y sus usos. | |
AR090726A1 (es) | Vacunas y procedimientos para tratar la enfermedad de lyme en perros |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |